Bachrodt Amy — SEC Form 4 filings
SEC reporting owner CIK 2050422. 7 Form 4 filings on record with FilingPulse; latest filed 2026-04-02.
Transaction summary — filings shown
Covers all 7 filings on record, filed 2025-09-24 to 2026-04-02. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 13 legs across 6 filings — 37,500 shares, $1,559,380 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 27.
- Largest priced transaction: sale of 9,400 shares @ $40.54 ($381,071) in Maze Therapeutics, Inc., filed 2025-12-31.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Maze Therapeutics, Inc. (MAZE) | SVP, Finance | 7 | — | 13 legs · 37,500 sh · $1,559,380 | 27 |
Form 4 filings — Bachrodt Amy
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-04-02 | 4 | Maze Therapeutics, Inc. (MAZE) | Option exercise (M): 2,500 @ $10.42 · Sale (S): 2,200 @ $29.32 · Sale (S): 300 @ $30.34 · Option exercise (M): 2,500 (derivative) @ $0 | EDGAR |
| 2026-03-03 | 4 | Maze Therapeutics, Inc. (MAZE) | Option exercise (M): 5,000 @ $10.42 · Sale (S): 1,300 @ $44.44 · Sale (S): 3,700 @ $45.47 · Option exercise (M): 5,000 (derivative) @ $0 · Grant/award (A): 32,000 (derivative) @ $0 · Grant/award (A): 16,000 (derivative) @ $0 | EDGAR |
| 2026-02-04 | 4 | Maze Therapeutics, Inc. (MAZE) | Option exercise (M): 4,844 @ $10.42 · Option exercise (M): 156 @ $10.42 · Sale (S): 200 @ $44.15 · Sale (S): 4,064 @ $46.03 · Sale (S): 736 @ $46.63 · Option exercise (M): 4,844 (derivative) @ $0 · +1 more | EDGAR |
| 2026-01-26 | 4 | Maze Therapeutics, Inc. (MAZE) | Option exercise (M): 2,497 @ $10.42 · Option exercise (M): 2,503 @ $10.42 · Sale (S): 5,000 @ $45.52 · Option exercise (M): 2,497 (derivative) @ $0 · Option exercise (M): 2,503 (derivative) @ $0 | EDGAR |
| 2026-01-06 | 4 | Maze Therapeutics, Inc. (MAZE) | Option exercise (M): 204 @ $10.42 · Option exercise (M): 4,796 @ $10.42 · Sale (S): 2,405 @ $38.70 · Sale (S): 2,595 @ $39.57 · Option exercise (M): 204 (derivative) @ $0 · Option exercise (M): 4,796 (derivative) @ $0 | EDGAR |
| 2025-12-31 | 4 | Maze Therapeutics, Inc. (MAZE) | Option exercise (M): 124 @ $10.42 · Option exercise (M): 9,876 @ $10.42 · Sale (S): 9,400 @ $40.54 · Sale (S): 600 @ $41.16 · Option exercise (M): 2,395 @ $10.42 · Option exercise (M): 2,605 @ $10.42 · +5 more | EDGAR |
| 2025-09-24 | 4 | Maze Therapeutics, Inc. (MAZE) | Grant/award (A): 22,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2050422 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →